Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Redwood Pharma

Less than 1K followers
All
Press releases
3rd party
ShowingAll content types
Regulatory press release7/28/2024, 12:30 PM

Redwood Pharma files for bankruptcy

Redwood Pharma
Regulatory press release6/26/2024, 9:00 AM

Redwood Pharma provides a new update regarding divestment of company assets

Redwood Pharma
Press release6/12/2024, 10:00 AM

Redwood Pharma provides an update on the process for divesting the company's assets

Redwood Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/23/2024, 11:00 AM

Redwood Pharma provides an update on the company's future

Redwood Pharma
Press release5/8/2024, 6:30 AM

Redwood Pharma's product RP501 attracted a lot of interest at ARVO in Seattle

Redwood Pharma
Press release5/7/2024, 6:30 AM

Two international companies begin due diligence on Redwood Pharma's product RP501 ahead of potential commercial agreements

Redwood Pharma
Press release5/6/2024, 1:00 PM

Redwood Pharma's board subscribes to units in the ongoing new issue

Redwood Pharma
Press release2/28/2024, 7:30 AM

Redwood Pharma's innovative dry eye treatment to be presented at ARVO in Seattle

Redwood Pharma
Press release12/20/2023, 8:10 AM

Redwood Pharma's CEO Martin Vidaeus in year-end interview

Redwood Pharma
Press release12/19/2023, 7:00 AM

Redwood Pharma to participate in the JP Morgan Healthcare Conference

Redwood Pharma
Regulatory press release11/30/2023, 7:30 AM

Redwood Pharma AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)

Redwood Pharma
Press release11/22/2023, 7:30 AM

Redwood Pharma to participate in the NLS Days partner conference in Copenhagen

Redwood Pharma
Press release10/19/2023, 9:15 AM

Redwood Pharma to participate in the BIO-Europe partnering conference in Munich

Redwood Pharma
Regulatory press release5/31/2023, 9:10 PM

Redwood Pharma presents positive results from a clinical study with RP501 against dry eye

Redwood Pharma
Press release3/17/2023, 12:00 PM

Redwood Pharma completes recruitment for clinical trial with RP501 for dry eye

Redwood Pharma
Press release1/24/2023, 7:30 AM

Redwood Pharma takes important steps towards the commercial production of its dry eye product

Redwood Pharma
Regulatory press release12/15/2022, 4:00 PM

Redwood Pharma enters partnership with Nextec medical in preparation for European market clearance of RP501

Redwood Pharma
Press release10/19/2022, 1:18 PM

Interview with CEO Martin Vidaeus of Redwood Pharma at BioStock Investor Meeting, Stockholm

Redwood Pharma
Press release10/14/2022, 6:30 AM

Redwood Pharma: Streamed video of CEO Martin Vidaeus presenting at Aktieportföljen Live in Stockholm, Sweden on Oct. 11, 2022

Redwood Pharma
Press release10/3/2022, 1:42 PM

Redwood Pharma to present at AKTIEPORTFÖLJEN LIVE SVERIGE in Stockholm on 11[th] of Oct. 2022 at 14:45

Redwood Pharma
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.